Calamos Wealth Management »

Halozyme Therapeutics shares owned by Calamos Wealth Management

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Calamos Wealth Management from 13F filings

Historical chart of Calamos Wealth Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Calamos Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Calamos Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $297k 259k 1.15
2025-06-30 $255k 256k 1.00
2025-03-31 $336k 316k 1.06
2024-12-31 $238k 249k 0.96
2024-09-30 $384k 383k 1.00
2023-06-30 $345k 414k 0.83
2023-03-31 $411k 484k 0.85
2022-12-31 $246k 252k 0.97
2022-09-30 $462k 544k 0.85